Dongwei Xue

443 total citations
18 papers, 336 citations indexed

About

Dongwei Xue is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dongwei Xue has authored 18 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dongwei Xue's work include Circular RNAs in diseases (4 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer Mechanisms and Therapy (2 papers). Dongwei Xue is often cited by papers focused on Circular RNAs in diseases (4 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer Mechanisms and Therapy (2 papers). Dongwei Xue collaborates with scholars based in China. Dongwei Xue's co-authors include Liming Dong, Yili Liu, Yanpei Li, Zhi Li, Jian Zhou, Xiyan Zhang, Chunlai Liu, Xiling Zhang, Xingwang Zhu and Xue Gong and has published in prestigious journals such as Molecular Cancer, International Journal of Biological Macromolecules and Oncotarget.

In The Last Decade

Dongwei Xue

18 papers receiving 334 citations

Peers

Dongwei Xue

PRM

ONCOL

IMMUN

Jintao Zhuang China

Yongchu Sun China

Saskia M. Bergevoet Netherlands

J. Schwarz Germany

Roberto Cirombella Italy

Matthew Tanner United States

Kanghua Xiao China

Wenkai Zhu China

Laura N. Mutton United States

Jintao Zhuang China

Dongwei Xue

250 ×1.0

162 ×1.0

71 ×1.3

PRM

46 ×0.9

ONCOL

17 ×0.4

IMMUN

Citations per year, relative to Dongwei Xue Dongwei Xue (= 1×) peers Jintao Zhuang

Countries citing papers authored by Dongwei Xue

Since Specialization

Citations

This map shows the geographic impact of Dongwei Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongwei Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongwei Xue more than expected).

Fields of papers citing papers by Dongwei Xue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongwei Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongwei Xue. The network helps show where Dongwei Xue may publish in the future.

Co-authorship network of co-authors of Dongwei Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Dongwei Xue. A scholar is included among the top collaborators of Dongwei Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongwei Xue. Dongwei Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Zhu, Xingwang, Jianxin Xue, Haifeng Jiang, & Dongwei Xue. (2024). CAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedside. Molecular Cancer. 23(1). 237–237. 11 indexed citations

Wang, Siqi, et al.. (2022). Current Researches on Nanodrug Delivery Systems in Bladder Cancer Intravesical Chemotherapy. Frontiers in Oncology. 12. 879828–879828. 13 indexed citations

Dong, Liming, et al.. (2021). LINC00511/miRNA-143-3p Modulates Apoptosis and Malignant Phenotype of Bladder Carcinoma Cells via PCMT1. Frontiers in Cell and Developmental Biology. 9. 650999–650999. 18 indexed citations

Zhu, Xingwang, et al.. (2021). Nodal is involved in chemoresistance of renal cell carcinoma cells via regulation of ABCB1. Journal of Cancer. 12(7). 2041–2049. 1 indexed citations

Liu, Jia, et al.. (2019). Anticancer evaluation of a novel dithiocarbamate hybrid as the tubulin polymerization inhibitor. Investigational New Drugs. 38(2). 525–532. 6 indexed citations

Zhang, Xiyan, Jian Zhou, Dongwei Xue, et al.. (2019). MiR-515-5p acts as a tumor suppressor via targeting TRIP13 in prostate cancer. International Journal of Biological Macromolecules. 129. 227–232. 61 indexed citations

Ming-shan, LI, Yili Liu, Jie Liu, et al.. (2019). Circ_0006332 promotes growth and progression of bladder cancer by modulating MYBL2 expression via miR-143. Aging. 11(22). 10626–10643. 23 indexed citations

Dong, Liming, et al.. (2018). LncRNA TINCR is associated with clinical progression and serves as tumor suppressive role in prostate cancer. Cancer Management and Research. Volume 10. 2799–2807. 41 indexed citations

Dong, Liming, Yanpei Li, Dongwei Xue, et al.. (2018). TRIP13 is a predictor for poor prognosis and regulates cell proliferation, migration and invasion in prostate cancer. International Journal of Biological Macromolecules. 121. 200–206. 33 indexed citations

10.

Zhang, Xiuwei, Dongwei Xue, Lingling Xie, et al.. (2018). Remodeling and spacing factor 1 overexpression is associated with poor prognosis in renal cell carcinoma. Oncology Letters. 15(3). 3852–3857. 4 indexed citations

11.

Dong, Liming, et al.. (2018). PCMT1 is an unfavorable predictor and functions as an oncogene in bladder cancer. IUBMB Life. 70(4). 291–299. 27 indexed citations

12.

Fu, Lin, Dongwei Xue, Xiupeng Zhang, et al.. (2017). Overexpression of Rsf-1 correlates with poor survival and promotes invasion in non-small cell lung cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 470(5). 553–560. 8 indexed citations

13.

Liu, Jia, et al.. (2017). Rab27A overexpression promotes bladder cancer proliferation and chemoresistance through regulation of NF-κB signaling. Oncotarget. 8(43). 75272–75283. 27 indexed citations

14.

Xue, Dongwei, Xiuwei Zhang, Xilin Zhang, et al.. (2015). Clinical significance and biological roles of TRIM24 in human bladder carcinoma. Tumor Biology. 36(9). 6849–6855. 24 indexed citations

15.

Zhang, Xiuwei, Songyan Chen, Dongwei Xue, et al.. (2015). Expression of Nemo-like kinase was increased and negatively correlated with the expression of TCF4 in lung cancers.. PubMed. 8(11). 15086–92. 7 indexed citations

16.

Liu, Chunlai, et al.. (2013). Endoscopic realignment in the management of complete transected ureter. International Urology and Nephrology. 46(2). 335–340. 14 indexed citations

17.

Liu, Yili, Yongzhi Li, Ning Li, et al.. (2011). Flexible ureteroscopy and holmium laser lithotripsy for treatment of upper urinary tract calculi in patients with autosomal dominant polycystic kidney disease. Urological Research. 40(1). 87–91. 12 indexed citations

18.

Liu, Chunlai, Dongwei Xue, Yili Liu, & Ping Wang. (2011). [Greenlight photoselective vaporization prostatectomy versus thulium laser vaporesection of the prostate for aged high-risk BPH patients with the prostate heavier than 80 g].. PubMed. 17(5). 431–4. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact